There is however a possibility that they had pathogenic changes in HLH-related genes that could have been overlooked during the study, like deep intronic changes or inversion in UNC13D. This confirms that a definite distinction between primary and secondary HLH is not possible in many clinical situations. This evidence concerns the gene UNC13D and hemophagocytic syndrome.